Schering Integration On Track, Bayer CEO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Schering AG stockholders to vote Sept. 13 on a domination and profit and loss transfer agreement with Bayer subsidiary Dritte BV.
You may also be interested in...
Merck KGaA Buys Serono, Gaining U.S. Commercial Organization
Merck acquires family-owned shares representing 64.5% of Serono's capital and will launch a tender offer for the remainder, at a total value of $13.27 bil.
Merck KGaA Buys Serono, Gaining U.S. Commercial Organization
Merck acquires family-owned shares representing 64.5% of Serono's capital and will launch a tender offer for the remainder, at a total value of $13.27 bil.
AstraZeneca, Schering AG Partner On Developmental SERD Breast Cancer Drug
Collaboration will build on AstraZeneca’s expertise with Faslodex.